Effect of Paclitaxel on Antitumor Activity of Cyclophosphamide: Study on Two Transplanted Tumors in Mice
| LEADER | caa a22 4500 | ||
|---|---|---|---|
| 001 | 605536813 | ||
| 003 | CHVBK | ||
| 005 | 20210128100854.0 | ||
| 007 | cr unu---uuuuu | ||
| 008 | 210128e20151101xx s 000 0 eng | ||
| 024 | 7 | 0 | |a 10.1007/s10517-015-3103-6 |2 doi |
| 035 | |a (NATIONALLICENCE)springer-10.1007/s10517-015-3103-6 | ||
| 245 | 0 | 0 | |a Effect of Paclitaxel on Antitumor Activity of Cyclophosphamide: Study on Two Transplanted Tumors in Mice |h [Elektronische Daten] |c [V. Kaledin, V. Nikolin, N. Popova, I. Pyshnaya, L. Bogdanova, T. Morozkova] |
| 520 | 3 | |a Antitumor effect of paclitaxel used as the monotherapy or in combination with cyclophosphamide was studied on CBA/LacSto mice with transplanted LS and RLS tumors characterized by high (LS) and low (RLS) sensitivity to cyclophosphamide. The therapeutic effects of cyclophosphamide and paclitaxel were summed in animals with drug-resistant RLS tumor, while combined use of these drugs in LS tumor highly sensitive to the apoptogenic effect of cyclophosphamide was no more effective than cyclophosphamide alone. | |
| 540 | |a Springer Science+Business Media New York, 2015 | ||
| 690 | 7 | |a malignant tumors |2 nationallicence | |
| 690 | 7 | |a cyclophosphamide |2 nationallicence | |
| 690 | 7 | |a paclitaxel |2 nationallicence | |
| 690 | 7 | |a apoptosis |2 nationallicence | |
| 700 | 1 | |a Kaledin |D V. |u Institute of Cytology and Genetics, Siberian Division of the Russian Academy of Sciences, Novosibirsk, Russia |4 aut | |
| 700 | 1 | |a Nikolin |D V. |u Institute of Cytology and Genetics, Siberian Division of the Russian Academy of Sciences, Novosibirsk, Russia |4 aut | |
| 700 | 1 | |a Popova |D N. |u Novosibirsk State University, Novosibirsk, Russia |4 aut | |
| 700 | 1 | |a Pyshnaya |D I. |u Institute of Chemical Biology and Basic Medicine, Siberian Division of the Russian Academy of Sciences, Novosibirsk, Russia |4 aut | |
| 700 | 1 | |a Bogdanova |D L. |u Institute of Molecular Pathology and Pathomorphology, Novosibirsk, Russia |4 aut | |
| 700 | 1 | |a Morozkova |D T. |u Institute of Molecular Pathology and Pathomorphology, Novosibirsk, Russia |4 aut | |
| 773 | 0 | |t Bulletin of Experimental Biology and Medicine |d Springer US; http://www.springer-ny.com |g 160/1(2015-11-01), 81-83 |x 0007-4888 |q 160:1<81 |1 2015 |2 160 |o 10517 | |
| 856 | 4 | 0 | |u https://doi.org/10.1007/s10517-015-3103-6 |q text/html |z Onlinezugriff via DOI |
| 898 | |a BK010053 |b XK010053 |c XK010000 | ||
| 900 | 7 | |a Metadata rights reserved |b Springer special CC-BY-NC licence |2 nationallicence | |
| 908 | |D 1 |a research-article |2 jats | ||
| 949 | |B NATIONALLICENCE |F NATIONALLICENCE |b NL-springer | ||
| 950 | |B NATIONALLICENCE |P 856 |E 40 |u https://doi.org/10.1007/s10517-015-3103-6 |q text/html |z Onlinezugriff via DOI | ||
| 950 | |B NATIONALLICENCE |P 700 |E 1- |a Kaledin |D V. |u Institute of Cytology and Genetics, Siberian Division of the Russian Academy of Sciences, Novosibirsk, Russia |4 aut | ||
| 950 | |B NATIONALLICENCE |P 700 |E 1- |a Nikolin |D V. |u Institute of Cytology and Genetics, Siberian Division of the Russian Academy of Sciences, Novosibirsk, Russia |4 aut | ||
| 950 | |B NATIONALLICENCE |P 700 |E 1- |a Popova |D N. |u Novosibirsk State University, Novosibirsk, Russia |4 aut | ||
| 950 | |B NATIONALLICENCE |P 700 |E 1- |a Pyshnaya |D I. |u Institute of Chemical Biology and Basic Medicine, Siberian Division of the Russian Academy of Sciences, Novosibirsk, Russia |4 aut | ||
| 950 | |B NATIONALLICENCE |P 700 |E 1- |a Bogdanova |D L. |u Institute of Molecular Pathology and Pathomorphology, Novosibirsk, Russia |4 aut | ||
| 950 | |B NATIONALLICENCE |P 700 |E 1- |a Morozkova |D T. |u Institute of Molecular Pathology and Pathomorphology, Novosibirsk, Russia |4 aut | ||
| 950 | |B NATIONALLICENCE |P 773 |E 0- |t Bulletin of Experimental Biology and Medicine |d Springer US; http://www.springer-ny.com |g 160/1(2015-11-01), 81-83 |x 0007-4888 |q 160:1<81 |1 2015 |2 160 |o 10517 | ||